Genome Editing Market size was valued at USD 6.25 Billion in 2024 and is projected to reach USD 16.40 Billion by 2033, exhibiting a CAGR of 11.2% from 2026 to 2033.
The South Korea genome editing market is projected to reach USD 439.7 million by 2030, growing at a CAGR of 21.2% from 2024 to 2030. This growth is driven by advancements in CRISPR/Cas9 technology, which accounted for 48.56% of the market share in 2024. The market is segmented into technologies such as CRISPR/Cas9, TALENs/MegaTALs, ZFN, and Meganuclease.
Key industry requirements include:
Biopharmaceutical Companies: Developing gene therapies targeting oncology, neurology, and rare diseases.
Agricultural Sector: Utilizing genome editing for crop improvement, focusing on traits like disease resistance and nutritional enhancement.
Research Institutions: Engaging in basic and translational research, supported by government-funded R&D projects.
Contract Research Organizations (CROs): Providing genome editing services for research and clinical applications.
The South Korean government has enacted the “Act on the Safety and Support for Advanced Regenerative Medicine and Advanced Biological Products” to regulate and support the development of genome editing technologies. This includes conditional approvals, priority screening, and customized examinations to accelerate the assessment process.
Challenges in the market involve regulatory uncertainties and ethical concerns, particularly regarding germline editing and human embryo research. To address these, public dialogue and bioethics committees are essential for ensuring responsible use of genome editing technologies.
Opportunities lie in therapeutic innovation, agricultural biotechnology, and industrial bioprocessing. The government's investment in biotechnology research and infrastructure, along with international collaborations, positions South Korea as a leading hub for genomic science and biotechnology.
Get an In-Depth Research Analysis of the South Korea Genome Editing Market Size And Forecast [2025-2032]
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Genome Editing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Genome Editing Market
CRISPR
Base Editing
Prime Editing
Zinc Finger Nucleases (ZFNs)
TALENs
Human Therapeutics
Animal Genetic Engineering
Plant Genetic Engineering
Microorganism Genetic Engineering
Gene Editing for Drug Discovery
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs (Contract Research Organizations)
Agrochemical Companies
Government Research Institutes
Target Identification
Delivery Methods
Editing Tools
Screening & Analysis
Reagents
Consumables
Instruments
Services
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Genome Editing Market Research Analysis
1. Introduction of the South Korea Genome Editing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Genome Editing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Genome Editing Market, By Type
6. South Korea Genome Editing Market, By Application
7. South Korea Genome Editing Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Genome Editing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/